CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Focus on MSN22h
British doctor shares 9 'crazy' differences between medication in England and AmericaFrom the food to the vocabulary, there are some huge differences between the US and the UK. Another one is the medication! A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback